Genome Editing

Tools like CRISPR and TALENs make specific changes to the DNA of plants, animals, and microorganisms without using foreign DNA.

Lux logo LUX TAKE:

Genome editing is the future of agriculture, food ingredients, and medical therapeutics, but CRISPR-cas9 is not the be-all, end-all genome editing approach. Look for alternative cas proteins and non-CRISPR-based tools as legitimate, affordable, widely applicable options rather than focusing solely on CRISPR-Cas9. For human therapeutics progress, focus on scientific and clinical trial results ...

Related companies Evolva, Cibus, Calyxt, Benson Hill Biosystems, Precision Biosciences, AgGenetics, enEvolv, Locus Biosciences, MicroSynbiotiX, Desktop Genetics, Caribou Biosciences, Inscripta, PLANTeDIT

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978